These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 22514340)

  • 1. Elite controllers with low to absent effector CD8+ T cell responses maintain highly functional, broadly directed central memory responses.
    Ndhlovu ZM; Proudfoot J; Cesa K; Alvino DM; McMullen A; Vine S; Stampouloglou E; Piechocka-Trocha A; Walker BD; Pereyra F
    J Virol; 2012 Jun; 86(12):6959-69. PubMed ID: 22514340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Breadth of Expandable Memory CD8+ T Cells Inversely Correlates with Residual Viral Loads in HIV Elite Controllers.
    Ndhlovu ZM; Stampouloglou E; Cesa K; Mavrothalassitis O; Alvino DM; Li JZ; Wilton S; Karel D; Piechocka-Trocha A; Chen H; Pereyra F; Walker BD
    J Virol; 2015 Nov; 89(21):10735-47. PubMed ID: 26269189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA class I-restricted T-cell responses may contribute to the control of human immunodeficiency virus infection, but such responses are not always necessary for long-term virus control.
    Emu B; Sinclair E; Hatano H; Ferre A; Shacklett B; Martin JN; McCune JM; Deeks SG
    J Virol; 2008 Jun; 82(11):5398-407. PubMed ID: 18353945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunodominant HIV-specific CD8+ T-cell responses are common to blood and gastrointestinal mucosa, and Gag-specific responses dominate in rectal mucosa of HIV controllers.
    Ferre AL; Lemongello D; Hunt PW; Morris MM; Garcia JC; Pollard RB; Yee HF; Martin JN; Deeks SG; Shacklett BL
    J Virol; 2010 Oct; 84(19):10354-65. PubMed ID: 20668079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxic CD8+ T Cells Expressing CXCR5 Are Detectable in HIV-1 Elite Controllers After Prolonged
    Adams P; Iserentant G; Servais JY; Vandekerckhove L; Vanham G; Seguin-Devaux C;
    Front Immunol; 2020; 11():622343. PubMed ID: 33717056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-2 production by polyfunctional HIV-1-specific CD8 T cells is associated with enhanced viral suppression.
    Akinsiku OT; Bansal A; Sabbaj S; Heath SL; Goepfert PA
    J Acquir Immune Defic Syndr; 2011 Oct; 58(2):132-40. PubMed ID: 21637109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative analysis of the capacity of elite suppressor CD4+ and CD8+ T cells to inhibit HIV-1 replication in monocyte-derived macrophages.
    Walker-Sperling VE; Buckheit RW; Blankson JN
    J Virol; 2014 Sep; 88(17):9789-98. PubMed ID: 24942573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of Abrupt Loss of Virus Control in a Cohort of Previous HIV Controllers.
    Rosás-Umbert M; Llano A; Bellido R; Olvera A; Ruiz-Riol M; Rocafort M; Fernández MA; Cobarsi P; Crespo M; Dorrell L; Del Romero J; Alcami J; Paredes R; Brander C; Mothe B
    J Virol; 2019 Feb; 93(4):. PubMed ID: 30487276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD8+ T Cell Breadth and Ex Vivo Virus Inhibition Capacity Distinguish between Viremic Controllers with and without Protective HLA Class I Alleles.
    Koofhethile CK; Ndhlovu ZM; Thobakgale-Tshabalala C; Prado JG; Ismail N; Mncube Z; Mkhize L; van der Stok M; Yende N; Walker BD; Goulder PJR; Ndung'u T
    J Virol; 2016 Aug; 90(15):6818-6831. PubMed ID: 27194762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotype, Polyfunctionality, and Antiviral Activity of
    Salido J; Ruiz MJ; Trifone C; Figueroa MI; Caruso MP; Gherardi MM; Sued O; Salomón H; Laufer N; Ghiglione Y; Turk G
    Front Immunol; 2018; 9():2443. PubMed ID: 30405632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune and viral correlates of "secondary viral control" after treatment interruption in chronically HIV-1 infected patients.
    Van Gulck E; Bracke L; Heyndrickx L; Coppens S; Atkinson D; Merlin C; Pasternak A; Florence E; Vanham G
    PLoS One; 2012; 7(5):e37792. PubMed ID: 22666392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T Cell Homeostasis Disturbances in a Cohort of Long-Term Elite Controllers of HIV Infection.
    Benito JM; Jiménez-Carretero D; Restrepo C; Ligos JM; Valentín-Quiroga J; Mahillo I; Cabello A; López-Collazo E; Sánchez-Cabo F; Górgolas M; Estrada V; Rallón N;
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38892124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infrequent recovery of HIV from but robust exogenous infection of activated CD4(+) T cells in HIV elite controllers.
    Julg B; Pereyra F; Buzón MJ; Piechocka-Trocha A; Clark MJ; Baker BM; Lian J; Miura T; Martinez-Picado J; Addo MM; Walker BD
    Clin Infect Dis; 2010 Jul; 51(2):233-8. PubMed ID: 20550452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Robust HIV-specific CD4+ and CD8+ T-cell responses distinguish elite control in adolescents living with HIV from viremic nonprogressors.
    Vieira VA; Millar J; Adland E; Muenchhoff M; Roider J; Guash CF; Peluso D; Thomé B; Garcia-Guerrero MC; Puertas MC; Bamford A; Brander C; Carrington M; Martinez-Picado J; Frater J; Tudor-Williams G; Goulder P
    AIDS; 2022 Jan; 36(1):95-105. PubMed ID: 34581306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV+ elite controllers have low HIV-specific T-cell activation yet maintain strong, polyfunctional T-cell responses.
    Owen RE; Heitman JW; Hirschkorn DF; Lanteri MC; Biswas HH; Martin JN; Krone MR; Deeks SG; Norris PJ;
    AIDS; 2010 May; 24(8):1095-105. PubMed ID: 20400885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated Expression of CD160 and 2B4 Defines a Cytolytic HIV-Specific CD8+ T-Cell Population in Elite Controllers.
    Pombo C; Wherry EJ; Gostick E; Price DA; Betts MR
    J Infect Dis; 2015 Nov; 212(9):1376-86. PubMed ID: 25883386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic and immunologic heterogeneity among persons who control HIV infection in the absence of therapy.
    Pereyra F; Addo MM; Kaufmann DE; Liu Y; Miura T; Rathod A; Baker B; Trocha A; Rosenberg R; Mackey E; Ueda P; Lu Z; Cohen D; Wrin T; Petropoulos CJ; Rosenberg ES; Walker BD
    J Infect Dis; 2008 Feb; 197(4):563-71. PubMed ID: 18275276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA B*5701-positive long-term nonprogressors/elite controllers are not distinguished from progressors by the clonal composition of HIV-specific CD8+ T cells.
    Mendoza D; Royce C; Ruff LE; Ambrozak DR; Quigley MF; Dang T; Venturi V; Price DA; Douek DC; Migueles SA; Connors M
    J Virol; 2012 Apr; 86(7):4014-8. PubMed ID: 22278241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune Responses in Controllers of HIV Infection.
    Kwaa AK; Blankson JN
    Annu Rev Immunol; 2024 Jun; 42(1):21-33. PubMed ID: 37827174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural suppression of human immunodeficiency virus type 1 replication is mediated by transitional memory CD8+ T cells.
    Killian MS; Johnson C; Teque F; Fujimura S; Levy JA
    J Virol; 2011 Feb; 85(4):1696-705. PubMed ID: 21147929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.